The level of uptake and retention of amino-containing drugs in large unilamellar vesicles (LUVs) following uptake in response to a transmembrane pH gradient (vpH) can vary dramatically depending on the drug. For example, the anticancer drugs doxorubicin and epirubicin can be readily retained, whereas the anticancer drug vincristine and the antibiotic ciprofloxacin tend to leak out rapidly. In this investigation, we examine the influence of the hydrophobicity of the entrapped amines (that induce the vpH) and the anionic lipid content of the LUV on drug retention. It is shown that entrapment of increasingly hydrophobic monoamines (methylamine to amylamine) all lead to an induced vpH of 3 units and essentially complete drug uptake under the conditions employed, but do not lead to improved retention of vincristine and ciprofloxacin. However, significantly improved retention could be achieved by substitution of the anionic lipid distearoylphosphatidylglycerol (DSPG) for distearoylphosphatidylcholine (DSPC) in the LUV bilayer. Further, it is shown that if the induced vpH is reduced to 1.4 units (driven by entrapped diamine) nearly 100% accumulation of doxorubicin and epirubicin could be achieved, whereas only 25% loading for vincristine and ciprofloxacin was observed. Taken together these results provide methodology for improving (weak base) drug retention in liposomes and indicate that drugs that can partition into the lipid bilayer exhibit improved uptake and retention characteristics. ß
Introduction
Liposomal formulations of anticancer drugs, such as doxorubicin or vincristine, and antibiotics, such as cipro£oxacin, can result in improved therapeutic activity and reduced toxic side e¡ects [1] . However, these drugs can exhibit signi¢cantly di¡erent uptake and retention properties in the large unilamellar vesicles (LUVs) usually employed for drug delivery. For example, both doxorubicin and vincristine can be readily accumulated into LUVs exhibiting a pH gradient [2, 3] , but vincristine leaks out much more rapidly than doxorubicin for LUVs with the same lipid composition [3] . Alternatively, cipro£oxacin can be accumulated in response to a pH gradient induced by entrapped ammonium sulfate [4] when the exterior pH is approximately 6, but leaks from these LUVs relatively quickly [5] . It is clearly important to be able to control the rate of leakage of drugs from LUV delivery systems, as LUVs which do not retain their contents in vivo cannot deliver them to target sites. As a result, the e¤cacy of liposomal formulations is highly sensitive to drug leakage rates. In the case of vincristine, for example, improved drug retention in LUVs dramatically improves antitumor activity [3] .
In this work, we investigate two methods of regulating drug release from LUVs following uptake in response to vpH. The ¢rst involves the use of sulfate salts of alkyl amines in place of ammonium sulfate. The increased hydrophobicity of amines with longer alkyl chains may be hypothesized to result in higher levels of encapsulated amine and increased partitioning into the inner monolayer of the LUVs, resulting in an increased positive surface charge and improved retention of the positively charged drug. The second approach is based on a model of drug uptake in response to a pH gradient which suggests that increased partitioning of drugs in the inner monolayer is correlated with high levels of entrapped drug and improved retention properties [2, 6] . Membranes composed of negatively charged lipids exhibit higher membrane^water partition coe¤cients for positively charged drugs, which should lead to improved retention properties according to this model.
It is shown that drug retention in LUVs containing alkylammonium sulfates of increasing hydrophobicity is not improved over LUVs containing ammonium sulfate. However, improved retention is observed in LUVs containing the negatively charged lipid phosphatidyl glycerol (PG). These results support the model suggesting higher membrane^water partition coe¤cients lead to improved drug uptake and retention properties.
Materials and methods

Preparation of LUVs
Distearoyl phosphatidylcholine (DSPC), dipalmitoyl PC (DPPC), palmitoyl-oleoyl PC (POPC) and egg sphingomyelin (SM) were purchased from Avanti Polar Lipids (Alabama, USA), and were greater than 99% pure. Distearoyl PG (DSPG) was purchased Multilamellar vesicles (MLVs) were formed by hydration of the lipid with a 300 mM aqueous solution of the alkylammonium sulfate salts followed by ¢ve freeze^thaw cycles. These MLVs were extruded 10 times [7] through an extrusion device obtained from Lipex Biomembranes (Vancouver, BC, Canada), ¢t-ted with two stacked Nuclepore polycarbonate ¢lters with a pore size of 100 nm. The extruder was equilibrated to 60³C. The mean diameter of the vesicles was measured with dynamic light scattering (Nicomp, Particle Sizing Systems, Santa Barbara, CA) and found to be 115 þ 20 nm.
Synthesis of amino compounds and formation of the gradient
Alkylammonium sulfate salts were synthesized by the addition of sulfuric acid to an aqueous solution of the appropriate amine under cooling and vigorous stirring until the pH of the solution was neutral. The molar ratio of amine to sulfuric acid was 2:1 except for ethylenediammonium sulfate where it was 1:1. About 95% of the water was then removed using a Brinkmann Rotavapor-R rotary evaporator at 506 0³C. The remaining water was removed azeotropically with absolute ethanol (¢ve to six additions) on the rotovap, giving a wet salt precipitate. The salt was washed with anhydrous ethylether and the solvent was removed by ¢ltration through a Buchner funnel. Residual solvent was removed under high vacuum overnight. Sulfate salts were identi¢ed by 13 C-NMR by comparison to the alkylammonium chloride salts. The latter were purchased from Sigma. Ammonium methylsulfate was prepared according to Werner [8] .
An amine gradient was generated by exchanging the extravesicular solution with 150 mM NaCl, pH 7.4 or a 2-(N-morpholino)ethanesulfonic acid (MES)/ NaCl bu¡er, 20/140 mM, pH 6.0 on Sephadex G-50 spin columns [9] . To show that this procedure removed the external amine quantitatively the external solution was £uorimetrically assayed for amine after the reaction with £uorescamine [10] . Gradients formed using packed columns of Sephadex G-50 (1.5U10 cm) gave similar results. In order to match physiological conditions, the extravesicular medium was about 300 mosmol/kg. The inside and the outside of the LUVs were therefore not osmotically balanced. Reduction of the amine concentration to 150 mM for monoamines instead of 300 mM and 300 mM EDAS instead of 600 mM had no major in£u-ence on the results. Table 1 gives the names, abbreviations and the chemical formulas of all amines used. pK values are given [11] . The pH and the osmolarity of the 300 mM aqueous solutions were measured at least three times and the mean values are given.
pH gradient and drug uptake
The pH gradient was determined using [ 14 C]-methylamine and was performed as previously described [12] .
Drugs were added to the liposome preparation (5 mM total lipid) to give a molar drug-to-lipid ratio of 0.2 for doxorubicin, epirubicin and cipro£oxacin and 0.03 for vincristine. The samples were incubated at 60³C. Aliquots were taken for determination of drug uptake at di¡erent time points. Unentrapped drug was removed by running the aliquots over Sephadex G-50 spin columns prior to detection of the liposomally entrapped drug. Doxorubicin and epirubicin concentrations were determined by measuring the absorption at 480 nm in a 1% Triton X-100 solution. Vincristine concentration was determined either from the absorption at 297 nm in 80% ethanol or from dual label scintillation counting using [ 3 H]vincristine. Cipro£oxacin concentrations were determined by dual label scintillation counting using [ 14 C]cipro£oxacin or, in some cases, from absorption readings at 273.5 nm after a Bligh^Dyer extraction [13] into 200 mM NaOH as aqueous phase. The results from UV spectrometry and radiolabel analysis were in very good agreement. The lipid concentration was determined from scintillation counting and phosphate assays. Doxorubicin (adriamycin RDF), epirubicin (pharmorubicin RDF) and vincristine sulfate (vincasar PFS) were obtained from Pharmacia (Mississauga, Ont., Canada) and [ 3 H]vincristine sulfate was obtained from Amersham (Oakville, Ont., Canada). Cipro£oxacin and [
14 C]cipro£oxacin were from Bayer (Leverkusen, Germany). Fig. 1 shows the chemical structures of epirubicin and doxorubicin, cipro£oxa-cin and vincristine and their pK values. Doxorubicin di¡ers from epirubicin only in the stereochemistry of the OH bearing C-4 on the amino sugar. The pK of doxorubicin is 8.6. Regarding the zwitterionic property of cipro£oxacin it is important to note that as the pK of the carboxyl function is rather high (pK 1 = 6.0) and the intraliposomal pH is very low the carboxyl groups are almost completely protonated. Thus the entrapped cipro£oxacin can be regarded as a weak base drug.
In vitro assay for drug retention
In vitro release experiments were carried out in test tubes by diluting samples after maximal drug uptake 1:1 (v/v) with normal mouse serum (Cedar Lane Laboratories, Hornby, Ont., Canada) followed by incubation at 37³C. Samples at various time points were taken and concentrations of entrapped drugs were determined as described for drug uptake experiments. For these experiments, the ratio of concentrations of mouse serum and total lipid is important [14] . A ratio of 1:10 (v/v) of mouse serum to sample liberated only 40% of encapsulated cipro£oxacin within 15 min compared to 90^95% with 1:1 mouse serum.
Results
Drug accumulation in response to monoamine sulfate gradients
It has previously been shown that when ammonium sulfate is entrapped within LUVs and exterior ammonium sulfate is removed, a transmembrane vpH is established that can drive the accumulation of drugs which are weak bases [4] . The vpH is set up due to the e¥ux of neutral ammonia molecules, each of which leaves a proton behind in the LUV interior, leading to a proton gradient according to the relation
The mechanism of loading of drugs in response to a pH gradient is depicted in Fig. 2 . In the present study, we hypothesized that sulfate salts of more hydrophobic amino compounds may lead to improved uptake and retention of weak base drugs. An increase in partitioning of the alkylamine into the inner monolayer of the LUVs may be expected to lead to higher levels of entrapped amino sulfate and the establishment of a positive surface charge at the inner monolayer interface, which may, in turn, inhibit e¥ux of the positively charged entrapped drug. In order to establish that alkylamines with increased alkyl chain length show higher membrane^water partitioning, the £uo-rescence of the surface potential probe TNS was measured in the presence of amylammonium sulfate and methylammonium sulfate. 2-(p-Toluidino)naphthalene-6-sulfonic acid (TNS) £uorescence increased in the presence of amylammonium sulfate, but not methylammonium, consistent with a higher membrane^water partition coe¤cient for the more hydrophobic compound (results not shown).
A variety of alkylammonium sulfates were synthesized (see Table 1 ) and entrapped (300 mM) in DSPC/ cholesterol (55/45 mol/mol) LUVs (100 nm diameter). After exchange of exterior alkylammonium sulfate for 150 mM NaCl pH 7.4 and incubation at 60³C for 15 min, a vpH of approximately 3 units was established, as shown in Fig. 3A . This vpH was the same for all alkylammonium sulfate salts employed, as assayed by the transbilayer distribution of trace levels of radiolabeled methylamine. This value of vpH corresponds well with the value expected on the basis of the transbilayer distribution of the alkylamine. In the case of entrapped methylammonium sulfate, for example, the methylamine concentration outside the LUVs after establishing the vpH was found to be 0.8 þ 0.05 mM and the internal methylamine concentration was 457 þ 50 mM, corresponding to a vpH of about 2.8 units. It should be noted that whereas other investigators [15] have found it necessary to reduce the pH of the ammonium sulfate solution to pH 2.5 in order to achieve good uptake of cipro£oxacin, no such adjustment in pH of the monoamines employed here was required.
Drug uptake also correlates well with the amount of amine crossing the membrane in exchange for the drug. A previous report suggests an exchange ratio of 1:4 for doxorubicin and NH 4 , concluding that loading was much lower than the loading capacity [4] . However, for a methylammonium sulfate gradient we found a 1:1 exchange of methylamine and drug for the monobasic drugs doxorubicin, epirubicin and cipro£oxacin while the ratio of vincristine in£ux to methylamine e¥ux was found to be about 1:2, consistent with the two basic groups of vincristine (data not shown). Thus e¥ux of entrapped amine is tightly coupled with drug in£ux.
The next set of experiments was aimed at determining the uptake and retention properties of doxorubicin, epirubicin, vincristine and cipro£oxacin for LUVs containing these alkylamines after establishing the pH gradient. As shown in Fig. 3B , all of these drugs exhibit 80% or higher loading levels after 5 min incubation (at 60³C) with DSPC/cholesterol LUVs (containing 300 mM ethylammonium sulfate) in the presence of drug at a drug to lipid ratio of 0.2 (mol/ mol) for doxorubicin, epirubicin and cipro£oxacin and 0.03 (mol/mol) for vincristine. This behavior was found to be representative for all the alkylamines employed as very similar levels of drug uptake were observed for all other species.
The retention properties of doxorubicin, epirubicin, cipro£oxacin and vincristine following uptake into DSPC/cholesterol LUVs were also found to be independent of the type of alkylammonium sulfate used (results not shown). Retention was, however, highly dependent on the particular drug employed. As shown in Fig. 4 , after uptake in response to entrapped methylammonium sulfate and gradient formation with 150 mM NaCl pH 7.4, on incubation at 37³C in the presence of 50% mouse serum, essentially all accumulated cipro£oxacin is released within 5 min and only 25% vincristine remains encapsulated after 1 h. This behavior contrasts strongly with the retention properties of doxorubicin and epirubicin, which exhibit little or no leakage over the 1-h incubation time.
Drug accumulation in response to diamine sulfate gradients
It has been shown previously that more doxorubicin is accumulated into LUVs exhibiting a vpH than would be expected on the basis of the pH gradient alone [2] . This has been attributed to partitioning of accumulated doxorubicin into the inner monolayer, which would give rise to doxorubicin concentration gradients which are larger than the proton concentration gradients according to the equation:
where K p is the membrane^water partition coe¤cient of the drug, V m is the volume of the LUV membrane and V i is the volume of the aqueous interior. For a 100-nm-diameter LUV, V m /V i V0.33 and thus for a membrane^water partition coe¤cient of V70, as has been determined for doxorubicin [2] , the concentration gradient of doxorubicin across the LUV membrane is approximately 20 times higher than would be predicted from the proton gradient. It is of interest to determine whether similar e¡ects are observed for poorly retained drugs such as vincristine and cipro£oxacin so that their reduced membrane^water partition coe¤cients are related to the shorter retention times. Accumulation in response to the entrapped monoamines, which give rise to an initial vpH of 3 units, results in nearly complete encapsulation of all the drugs employed under the conditions used here. At some smaller vpH it would be expected from Eq. 1, that drugs exhibiting large membrane^water partition coe¤cients should show improved uptake over those with smaller partition coe¤cients. In this regard, assuming the neutral form is membrane permeable, it is straightforward to show that the proton gradient resulting from an entrapped diamine will obey the relationship [H ] 
1a2 , and thus the vpH induced should be half that observed for the monoamines. As shown in The accumulation of doxorubicin, epirubicin, cipro£oxacin and vincristine in response to this reduced vpH is illustrated in Fig. 5B . It may be observed that whereas more than 80% of available doxorubicin and epirubicin are accumulated over the 30 min incubation period, less than 25% of the cipro£oxacin and vincristine is sequestered. This behavior is consistent with reduced membrane^water partition coe¤cients for cipro£oxacin and vincristine as compared to doxorubicin and epirubicin. into 100 nm DSPC/cholesterol (55:45 mol/mol) LUVs using 300 mM EDAS at 60³C for 30 min. More than 80% doxorubicin and epirubicin are accumulated in response to a pH gradient of 1.4 units, while less than 25% cipro£oxacin and vincristine is taken up.
Drug accumulation and retention in LUVs containing anionic lipids
It is well known that the membrane^water partition coe¤cients of charged molecules are highly sensitive to the charge on the membrane [16] . It would be expected, for example, that the use of negatively charged lipids in the LUVs experiencing a vpH would increase the membrane^water partition coe¤-cients of the positively charged drugs employed here. In turn, according to Eq. 1, it would be expected that these drugs should exhibit improved retention properties in LUVs containing anionic lipids. In order to test this possibility, the retention properties of cipro£oxacin and vincristine were examined in LUVs containing varying amounts of the negatively charged phospholipid, distearoylphosphatidylglycerol (DSPG). Using a methylammonium sulfate gradient (external methylammonium sulfate was exchanged with MES/NaCl bu¡er at pH 6.0), essentially complete uptake of all drugs was reached after 15 min of incubation at 60³C.
As shown in Fig. 6A , the half-times for retention of cipro£oxacin in the presence of serum are increased from less than 10 min for DSPC/cholesterol (55:45 mol/mol) LUVs to approximately 30 min for DSPG/cholesterol (55:45 mol/mol) LUVs. Alternatively, for vincristine (Fig. 6B) , the inclusion of as little as 15 mol% DSPG in the DSPC/cholesterol LUVs increases the retention half-times from 1 h to approximately 2 h, and considerably better retention is observed for the DSPG/cholesterol LUVs. The pH of the external serum solution rose to 8.2 during the course of this experiment. It should be noted that the improved drug retention for vincristine and cipro£oxacin with PG-containing vesicles compared to PC-containing vesicles was more pronounced at this higher external pH. Although a signi¢cantly higher amount of amine is associated with PG vesicles, about 30% more than with PC vesicles, control experiments showed that this does not in£uence retention. Uptake and retention of doxorubicin and epirubicin in PG containing vesicles was similar to that observed for neutral PC vesicles. Both drugs were readily taken up and did not leak out of vesicles diluted with mouse serum (1:1) during a 1-h incubation (data not shown).
Discussion
This study was performed to identify parameters which lead to enhanced retention of amino containing drugs in LUV systems exhibiting a transmembrane pH gradient (interior acidic). The results pre- sented indicate that factors that lead to enhanced drug partitioning into the LUV lipid bilayer improve retention properties. The observations that support this conclusion include the lack of improvement in retention for uptake in response to entrapped hydrophobic alkylamines, the much higher uptake of doxorubicin and epirubicin versus cipro£oxacin and vincristine for LUVs containing diammonium sulfate and the improved retention of cipro£oxacin and vincristine in LUVs comprised, at least in part, of the negatively charged phospholipid, phosphatidylglycerol. Finally, the results presented here provide potential methods to improve drug retention and potency in vivo. We discuss these aspects in turn.
The fact that increased hydrophobicity of entrapped amino compounds does not a¡ect the uptake and retention of the drugs employed here suggests that a positive surface charge on the inner monolayer^water interface does not in£uence the uptake and release of entrapped positively charged drug. The largest e¡ects would be expected for entrapped amylammonium sulfate, where the hydrophobic pentyl chain should lead to the largest partitioning effects and the largest inner monolayer surface charge; however, retention of cipro£oxacin and vincristine on incubation with 50% mouse serum was not improved.
The uptake properties of doxorubicin and epirubicin versus vincristine and cipro£oxacin in response to the reduced vpH of 1.5 units achieved in response to entrapped diammonium sulfate are of particular interest. As indicated by Eq. 1, the ability of a drug to partition into the inner monolayer after uptake is expected to lead to equilibrium transmembrane concentrations of drug which exceed the transmembrane concentration of protons by the ratio 1+K p V m /V i , where K p is the membrane^water partition coe¤-cient. For drugs such as doxorubicin, for which K p V70 [2] , this has the e¡ect of causing much higher drug accumulation into LUVs than would be expected on the basis of the vpH. For example, for a drug with K p = 0, the equilibrium transbilayer drug concentration gradient is 32 for a vpH of 1.5 units, whereas if K p = 70 the equilibrium concentration gradient is about 760. Under the conditions employed for the results shown in Fig. 5 the expected encapsulation e¤ciency resulting from a vpH of 1.5 units would be 85% for K p = 70 and only 19% for K p = 0.
As a result, the much larger accumulation of doxorubicin and epirubicin as compared to vincristine and cipro£oxacin for vpH = 1.5 (Fig. 4B) could be directly related to di¡erences in the membrane^water partition coe¤cients of these drugs.
The improvement in retention for vincristine and cipro£oxacin entrapped in LUVs containing phosphatidylglycerol is also clearly consistent with the partitioning model. It should be noted that in the absence of membrane partitioning e¡ects the presence of PG would be expected to increase, rather than decrease, membrane permeability. This is because negatively charged lipids generally give rise to more permeable bilayers than phosphatidylcholine bilayers with the same acyl chain composition [17] and also give rise to signi¢cantly higher binding of serum proteins [18] , which strongly promote leakage.
It could be argued that the drugs with higher pK values should exhibit superior retention. Higher pK values will lead to lower concentrations of the deprotonated, membrane permeable, form of the drug. However, the rates of leakage do not correlate with the pK values of the drugs employed here. The pK values of the amino functions are 7.4 for vincristine, 7.7 for epirubicin, 8.6 for doxorubicin and 8.8 for cipro£oxacin (Fig. 1 ). Epirubicin and vincristine on the one hand and doxorubicin and cipro£oxacin on the other hand have very similar pK values. Their retention properties are, however, very di¡erent. While epirubicin and doxorubicin are readily retained, vincristine and cipro£oxacin leak out rapidly. This indicates that the di¡erent retention properties of the drugs are not related to their pK values.
The results presented here are also relevant to the di¤culty in discerning between membrane partitioning and precipitation of accumulated drug in the LUV interior as the cause of drug encapsulation levels which exceed values expected on the basis of transmembrane pH gradients. As pointed out elsewhere, if all of the accumulated drug is in the aqueous interior the concentration of drug can exceed the solubility of the drug by orders of magnitude, potentially leading to drug precipitation in the vesicle interior [2, 4, 6] . This would have similar e¡ects as drug partitioning into the membrane, as more drug would be present in the vesicle interior than would be expected on the basis of the vpH. The observation that improved retention is observed for the PG-contain-ing LUVs is consistent with the partitioning model, and o¡ers an interesting direction to pursue to resolve this area of contention.
A ¢nal point is that the results presented here demonstrating improved drug retention in vitro for vesicles containing negatively charged lipids, such as PG, o¡er a potential method for improving drug retention in vivo, which, for drugs such as vincristine, can result in signi¢cant improvements in e¤-cacy. For example, methods resulting in improved retention of vincristine in liposomes in vitro resulted in improved retention in vivo [3] and dramatically enhanced e¤cacy in a murine P388 lymphocytic leukemia model [19] . Future studies will address the possibility that inclusion of negatively charged lipids in liposomes containing vincristine can o¡er similar bene¢ts.
